XML 31 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Mar. 26, 2024
Jun. 30, 2023
Document and Entity Information        
Document Type 10-K      
Document Annual Report true      
Document Period End Date Dec. 31, 2023      
Document Transition Report false      
Entity File Number 001-39202      
Entity Registrant Name Annovis Bio, Inc.      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 26-2540421      
Entity Address, Address Line One 101 Lindenwood Drive, Suite 225      
Entity Address, City or Town Malvern      
Entity Address, State or Province PA      
Entity Address, Postal Zip Code 19355      
City Area Code 484      
Local Phone Number 875-3192      
Title of 12(b) Security Common Stock, par value $0.0001 per share      
Trading Symbol ANVS      
Security Exchange Name NYSE      
Entity Current Reporting Status Yes      
Entity Well Known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company true      
Entity Ex Transition Period true      
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] false      
Entity Shell Company false      
Entity Public Float       $ 91,527,093
Entity Common Stock, Shares Outstanding     11,011,299  
Entity Central Index Key 0001477845      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2023      
Document Fiscal Period Focus FY      
Amendment Flag false      
Auditor Name Ernst & Young LLP WithumSmith+Brown, PC    
Auditor Location Philadelphia, Pennsylvania East Brunswick, New Jersey    
Auditor Firm ID 42 100